Agfa-Gevaert NV (AFGVF) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello and welcome to the Agfa Group Q2 2025 results call. Please note this call is being recorded and for the duration of the call, your lines will be on listened only. However, you will have the opportunity to ask questions at the end of the call. This can be done by pressing star 1 on your telephone keypad to register your question. If you require assistance at any point, please press star 0 and you will be connected to an operator. I will now hand you over to your host, Pascal Duery, CEO, to begin today's conference. Please go ahead. Thank you very much, and good morning to everyone, and thank you for attending. I'm here in the room with our CFO, Fiona Lam, with our Investment Relations Director, Vivian Dictus, and members of the Executive Committee, and we're going to walk you through the set of the results for Q2 and the first half of the year. I think first message is on the business. As you've seen, very contrasted situation between our three businesses, our three main businesses. I mean, a strong healthcare IT, and I'll come back to that, but the P&L delivery was very good, and we only have positive things to say going forward for healthcare IT. DPC, disappointing growth, actually a lack of growth, especially in our growth engines area. There is a trough in the market regarding green hydrogen projects. And digital printing equipment sales were impacted by the market context, but nothing is broken. And if anything, we continue to progress in our markets. And, of course, regarding the film activity, we have seen, I would say, a faster decline of the medical film market, faster than anticipated. And immediately, I can tell you that this will call for additional restructuring and efforts, not only in product supply, but also in our go-to-market. This is something...